Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001367644-23-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | EBS | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $12.38 | -971 | 86.6K | -1% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 971 | $12.38 | 86,645 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |